Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
hepatitis b/protease
O link é salvo na área de transferência
5 resultados
DNA sequence encoding modified hepatitis B virus surface antigen P31 protein
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
Modified hepatitis B virus surface antigen P31 and production thereof
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD OF INDUSTRIAL UTILITY
This invention relates to novel proteins useful as vaccines and a method of producing the same.
BACKGROUND ART
Type B hepatitis is a viral disease which occurs frequently in particular in the tropics of Africa, in Southeast Asia and in the Far East. Hepatitis B is
Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agents
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention relates to serine protease inhibitor Kazal (SPIK/SPINK/PSTI) and more specifically, its inhibitors and the use of inhibitors of SPIK as anti-cancer agents and anti-viral agents such as hepatitis B and C virus (HBV and HCV).
2.
Live, attenuated rubella vector to express vaccine antigens
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
FIELD
This disclosure relates to the field of viral vectors, specifically to a live, attenuated rubella viral vector platform capable of expressing a heterologous antigen, and the use of this platform to induce an immune response.
BACKGROUND
The worldwide spread of human immunodeficiency
Drug with antiviral activity (variants)
Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Phase of International Patent Application No. PCT/RU2016/000197, filed on Apr. 6, 2016, which published as WO 2016/159836 A1 on Oct. 6, 2016, and claims priority to Russian Patent Application No. 2015113254, filed on Apr. 3,
O mais completo banco de dados de ervas medicinais apoiado pela ciência
- Funciona em 55 idiomas
- Curas herbais apoiadas pela ciência
- Reconhecimento de ervas por imagem
- Mapa GPS interativo - marcar ervas no local (em breve)
- Leia publicações científicas relacionadas à sua pesquisa
- Pesquise ervas medicinais por seus efeitos
- Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes
Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas
